ATTENDANCE FORM
8th NORTH WEST DIABETES & CARDIOVASCULAR DISEASE UPDATE 8th May 2013
Free entry for healthcare professionals. Limited number of places available. To reserve
your place, please complete the form and return at your earliest convenience to:
Email: mark.woodcock@cmft.nhs.uk (preferred method of reply,
with information requested below)
Fax: 0161 276 4684 (f.a.o. Mark Woodcock)
Phone: 0161 276 8946
Post: Mark Woodcock, Cardiovascular Trials Unit, Central
Manchester University Hospitals NHS Foundation Trust, Ground
Floor, Old St Mary's Building, Hathersage Road, Manchester, M13
9WL.
[
] Yes, I am able to attend the meeting on Wednesday 8th May 2013
[ ]
I would like to be contacted for future events
CORRESPONDENCE DETAILS
Title: ………………………..
Position:…………………………………………………………………..
Name: ………………………………………………………………………………………………………….
GP Surgery/Hospital: .…….………………………………………………………………………………….
Address: ………………………………………………………………………………………………………..
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
Postcode: …………………………………………………………………………….....................................
Daytime Tel: ……………………………………………Mobile: ………….………....................................
Email Address( required for confirmation and reminder):
…………………………………………………
Please state any dietary requirements: …………………………………………………………………….
Signature:
……………………………………………………………………………………………………………
Date: ……………………………………………………………………………………………………………
The personal data and sensitive personal data (as defined by the Data Protection Act 1998) supplied
by you in response to this form is required for accommodation, registration and associated records
keeping purposes relating to the above event. By completing and returning this form, you agree that
this data may be used, disclosed and held on a ‘need to know’ basis for these purposes by the
Invitation
th
8
NORTH WEST
DIABETES &
CARDIOVASCULAR UPDATE
Wednesday 8th May 2013
9am to 4pm
De Vere Whites, Reebok Stadium, De
Havilland Way, Bolton, BL6 6SF
Organised by
Dr Handrean Soran & Dr Naveed Younis
The organisers will not receive speaker honorarium or any other fee for chairing the sessions
and organising the meeting
CPD accreditation (5 points) applied for
University of Manchester
The Centre for Endocrinology &
Diabetes
This meeting has been funded by Bristol-Myers Squibb and AstraZeneca, who had no input into
speaker selection and content.
8Th NORTH WEST
DIABETES & CARDIOVASCULAR UPDATE
A distinguished faculty of experts welcomes you to join them at the
eighth North West diabetes and cardiovascular disease update meeting
Professor Clifford Bailey, Dr Jennifer Beynon, Dr Farzin
Fath-Ordoubadi, Professor Peter Grant, Dr Miles Riddle,
Dr Handrean Soran & Dr Naveed Younis
We look forward to meeting you at this event
Educational objectives
•
Aim of session 1,
The aim of this session is to review management of type 1 diabetes, challenges and
therapeutic options. The speaker will also address individualising insulin choice
and regimens. The second talk will focus on managing diabetes in the peadiatric
population and the inherent challenges
•
Aim of session 2
The first talk will provide a review and an update on new therapeutic options for type
2 diabetes and their role in patient management. The speaker will also provide an
update on the place of these new guidelines in the management of type 2
diabetes.
The second talk will focus on difficult cases in the management of Type 2 diabetes.
•
Aim of session 3
This session covers and updates on hyperlipidaemia, macrovascular complications of
type 2 diabetes.
The first talk is on macrovascular disease in type 2 diabetes. This talk will explores the
impact of glycaemic control, lipid modification therapy and lowering blood
pressure on prevention of macrovascular disease in type 2 diabetes.
The second talk will provide a review and an update on management of
hyperlipidaemia and recent trials outcomes. The speaker will also present an
update on national and international guidelines. The talk will include interactive
case based discussions.
The third talk addresses the prevalence of coronary heart disease in patients with type
2 diabetes, when to investigate and refer to cardiology clinics. Management and
challenges facing cardiologists will also be discussed.
Agenda
0830 – 0920
Registration
09.20 – 09.30
Welcome Handrean Soran
Session 1
Chair Dr Naveed Younis
0930 – 1010
Management options of type 1 diabetes; challenges and therapeutic options. An
interactive case based discussion.
Dr Jenny Beynon, Consultant Physician, University Hospital South Manchester.
Q&A session
1010 – 1050
Challenges in managing Paediatric Diabetes
Dr Miles Riddle, Consultant Paediatrician, University Hospital South Manchester.
Q&A session
1050 – 1120
Tea & Coffee
Session 2
Chair Dr Handrean Soran
1120 – 1200
New therapeutic agents and their place in guidelines and management of type 2 diabetes.
Professor Clifford Bailey, Aston University, Birmingham, UK
Q&A session
12.00 – 12.40
Type 2 diabeets: selecting the right treatment for the right patient.
Dr Naveed Younis , Consultant Physician, University Hospital South Manchester.
Q&A session
12.40 - 13.50
Lunch & Networking
Session 3
Chair Dr Naveed Younis
1350 – 1430
Prevention of Cardiovascular Disease in Diabetes: Is Glucose Lowering Enough?
Professor Peter Grant, Leeds University, Leeds, UK.
Q&A session
1430 – 15.10
Hyperlipidaemia: what is new?
Dr Handrean Soran, Consultant Physician and Endocrinologist, Central Manchester
University Hospitals NHS Foundation Trust.
Q&A
1510 – 1550
Coronary heart disease in patients with diabetes and dysglycaemia: diagnosis,
management and challenges.
Dr Farzin Fath-Ordoubadi, Consultant Cardiologist, Central Manchester University Hospitals
NHS Foundation Trust
Q&A session
1550 -1600
Summary and close